Clinical trial
Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00002880 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00002880 |
|---|---|
| Title | Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma |
| Official title | PHASE II STUDY OF ORAL ETOPOSIDE WITH PHARMACODYNAMIC MODELING IN RELAPSED NON-HODGKIN'S LYMPHOMA (IWF GRADES A-H) |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | Etoposide phosphate |
| Enrollment | 53 |
| Start date | Nov 1, 1996 |
| Primary completion | Jan 1, 2001 |
| Completion | Jan 1, 2008 |
| First posted | May 21, 2004 |
| Last update posted | Jun 28, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: